|
1
|
Antiretroviral-drug resistance among patients recently infected with HIV.
|
N Engl J Med
|
2002
|
9.70
|
|
2
|
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection.
|
J Infect Dis
|
2011
|
2.34
|
|
3
|
Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
|
J Immunol
|
2007
|
2.30
|
|
4
|
Inadequate T follicular cell help impairs B cell immunity during HIV infection.
|
Nat Med
|
2013
|
2.29
|
|
5
|
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.
|
J Infect Dis
|
2011
|
2.26
|
|
6
|
HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
|
Retrovirology
|
2006
|
2.17
|
|
7
|
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
|
J Infect Dis
|
2003
|
2.04
|
|
8
|
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
|
AIDS
|
2002
|
2.02
|
|
9
|
Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
|
Virology
|
2008
|
1.81
|
|
10
|
Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
|
J Virol
|
2010
|
1.80
|
|
11
|
Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.
|
Blood
|
2012
|
1.62
|
|
12
|
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection.
|
J Acquir Immune Defic Syndr
|
2009
|
1.46
|
|
13
|
Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.
|
J Virol
|
2003
|
1.40
|
|
14
|
Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2008
|
1.40
|
|
15
|
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.
|
AIDS
|
2009
|
1.35
|
|
16
|
Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms.
|
AIDS Res Hum Retroviruses
|
2005
|
1.31
|
|
17
|
HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.
|
J Virol
|
2011
|
1.26
|
|
18
|
Incomplete antibody evolution and seroreversion after treatment of primary HIV type 1 infection: what is the clinical significance?
|
Clin Infect Dis
|
2005
|
1.18
|
|
19
|
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.
|
J Acquir Immune Defic Syndr
|
2008
|
1.15
|
|
20
|
Humanized Rag1-/- γc-/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes.
|
PLoS One
|
2011
|
1.09
|
|
21
|
Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy.
|
AIDS
|
2004
|
1.03
|
|
22
|
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study.
|
J Acquir Immune Defic Syndr
|
2003
|
1.01
|
|
23
|
CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women.
|
J Acquir Immune Defic Syndr
|
2012
|
1.01
|
|
24
|
CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV.
|
Blood
|
2003
|
1.00
|
|
25
|
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
|
J Infect Dis
|
2012
|
0.98
|
|
26
|
Phenotypic and functional characterization of HIV-1-specific CD4+CD8+ double-positive T cells in early and chronic HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2009
|
0.95
|
|
27
|
Immunophenotypic alterations in acute and early HIV infection.
|
Clin Immunol
|
2007
|
0.94
|
|
28
|
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection.
|
J Virol
|
2004
|
0.93
|
|
29
|
Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
|
J Virol
|
2010
|
0.93
|
|
30
|
GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo.
|
PLoS One
|
2011
|
0.92
|
|
31
|
Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases.
|
J Infect Dis
|
2004
|
0.90
|
|
32
|
Initial linkage and subsequent retention in HIV care for a newly diagnosed HIV-infected cohort in Denver, Colorado.
|
J Int Assoc Provid AIDS Care
|
2013
|
0.90
|
|
33
|
Role of Baseline pol Genotype in HIV-1 Fitness Evolution.
|
J Acquir Immune Defic Syndr
|
2003
|
0.89
|
|
34
|
Microanatomic relationships between CD8+ cells and HIV-1-producing cells in human lymphoid tissue in vivo.
|
J Acquir Immune Defic Syndr
|
2003
|
0.88
|
|
35
|
Challenges in the study of patients with HIV type 1 seroconversion.
|
Clin Infect Dis
|
2005
|
0.85
|
|
36
|
alpha-Defensins 1, 2, and 3 are expressed by granulocytes in lymphoid tissues of HIV-1-seropositive and -seronegative individuals.
|
J Acquir Immune Defic Syndr
|
2006
|
0.84
|
|
37
|
Mycobacterium kansasii cutaneous abscesses occurring as immune reconstitution inflammatory syndrome.
|
Int J Tuberc Lung Dis
|
2011
|
0.83
|
|
38
|
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174.
|
AIDS Res Hum Retroviruses
|
2010
|
0.82
|
|
39
|
Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.
|
AIDS Res Hum Retroviruses
|
2014
|
0.82
|
|
40
|
Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.
|
AIDS Patient Care STDS
|
2014
|
0.80
|
|
41
|
Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells.
|
AIDS
|
2003
|
0.79
|
|
42
|
SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.
|
AIDS Res Hum Retroviruses
|
2008
|
0.79
|
|
43
|
CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.
|
J Infect Dis
|
2013
|
0.78
|
|
44
|
Effects of HIV-1 gp120 and protease inhibitors on apoptotic susceptibility of CD34+ hematopoietic progenitor cells.
|
J Acquir Immune Defic Syndr
|
2011
|
0.77
|
|
45
|
Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS.
|
AIDS
|
2009
|
0.76
|
|
46
|
Safety of excisional inguinal lymph node biopsies performed for research purposes in HIV-1-infected women and men.
|
Surg Infect (Larchmt)
|
2014
|
0.76
|
|
47
|
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.
|
J Acquir Immune Defic Syndr
|
2010
|
0.75
|